Radiopharm Theranostics

(ASX) RAD

Current PriceA$0.02

Market CapA$70.88M

Since IPO (2021)-95%

5 YearN/A

1 Year-17%

1 Month-5%

Radiopharm Theranostics Financials at a Glance

Market Cap

A$70.88M

Revenue (TTM)

A$15.09M

Net Income (TTM)

-A$86.86M

EPS (TTM)

-A$0.02

P/E Ratio

-1.32

Dividend

A$0.00

Beta (Volatility)

-0.13 (Low)

Dividend

A$0.00

Beta (Volatility)

-0.13 (Low)

Price

A$0.02

Volume

1,626,097

Open

A$0.02

Price

A$0.02

Volume

1,626,097

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.04

Estimated Earnings Date

Sep 24, 2026

Dividend

A$0.00

Beta (Volatility)

-0.13 (Low)

Price

A$0.02

Volume

1,626,097

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.04

Estimated Earnings Date

Sep 24, 2026

RAD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Radiopharm Theranostics

Industry

Biotechnology

Sector

Health Care

CEO

Riccardo Canevari

Website

radiopharmtheranostics.com

Headquarters

Carlton, VIC 3053, AU

RAD Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

-86%

Return on Capital

-66%

Return on Assets

-49%

Earnings Yield

-75.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$70.88M

Shares Outstanding

3.54B

Volume

1.63M

Avg. Volume

2.42M

Financials (TTM)

Gross Profit

A$9.81M

Operating Income

-A$38.17M

EBITDA

-A$31.65M

Operating Cash Flow

-A$36.65M

Capital Expenditure

A$0.00

Free Cash Flow

-A$36.65M

Cash & ST Invst.

A$29.12M

Total Debt

A$0.00

Radiopharm Theranostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$1.39M

-65.9%

Gross Profit

-A$1.25M

+20.3%

Gross Margin

-90.30%

N/A

Market Cap

A$70.88M

N/A

Market Cap/Employee

A$5.06M

N/A

Employees

N/A

Net Income

-A$26.97M

-8.9%

EBITDA

-A$29.75M

-9.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$34.52M

+1722.4%

Total Debt

A$0.00

N/A

Accounts Receivable

A$11.36M

+157.6%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-49.29%

N/A

Return on Invested Capital

-65.55%

N/A

Free Cash Flow

-A$22.67M

-92.6%

Operating Cash Flow

-A$22.67M

-92.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PTX.AXPrescient Therapeutics Limited

PTX.AXPrescient Therapeutics LimitedA$0.07+0.00%

ATX.AXAmplia Therapeutics Limited

ATX.AXAmplia Therapeutics LimitedA$0.12-4.17%

CTE.AXCryosite Limited

CTE.AXCryosite LimitedA$1.06+0.00%

DOC.AXDoctor Care Anywhere Group PLC

DOC.AXDoctor Care Anywhere Group PLCA$0.13-5.66%

ADO.AXAnteoTech Limited

ADO.AXAnteoTech LimitedA$0.03+10.34%

CSX.AXCleanSpace Holdings Limited

CSX.AXCleanSpace Holdings LimitedA$0.41+2.50%

NSB.AXNeuroScientific Biopharmaceuticals Limited

NSB.AXNeuroScientific Biopharmaceuticals LimitedA$0.06-6.06%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$185.00-0.04%

NOKNokia

NOKNokia$13.49-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.99+0.04%

TAT&T

TAT&T$22.01-0.02%

QSQuantumScape

QSQuantumScape$8.04+0.17%

FLEXFlex

FLEXFlex$147.61+0.03%

CMCSAComcast

CMCSAComcast$22.43-0.01%

Questions About RAD

What is the current price of Radiopharm Theranostics?

Radiopharm Theranostics is trading at A$0.02 per share.

What is the 52-week range for Radiopharm Theranostics?

Over the past 52 weeks, Radiopharm Theranostics has traded between A$0.02 and A$0.04.

How much debt does Radiopharm Theranostics have?

As of the most recent reporting period, Radiopharm Theranostics reported total debt of A$0.00.

How much cash does Radiopharm Theranostics have on hand?

Radiopharm Theranostics reported A$29.12M in cash and cash equivalents in its most recent financial results.

What is Radiopharm Theranostics’s dividend yield?

Radiopharm Theranostics does not currently have a dividend yield.

Radiopharm Theranostics

Radiopharm Theranostics Financials at a Glance

RAD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Radiopharm Theranostics

RAD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Radiopharm Theranostics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RAD

What is the current price of Radiopharm Theranostics?

What is the 52-week range for Radiopharm Theranostics?

How much debt does Radiopharm Theranostics have?

How much cash does Radiopharm Theranostics have on hand?

What is Radiopharm Theranostics’s dividend yield?

Premium Investing Services